The Pharma Data

JULY 21, 2021

vice president, global therapeutic area head, eye care, AbbVie. This allows for an increased depth of focus without compromising distance vision. Robinson , M.D., DURYSTA Consumer Indications and Usage and Important Safety Information. For more information about AbbVie, please visit us at www.abbvie.com.

Production 52

Production Doctors Doctor Medicine 52

XTalks

AUGUST 2, 2023

In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. For example, Ocrevus will be challenged by Novartis’ Kesimpta (ofatumumab) and TG Therapeutics’ Briumvi (ublituximab). But all three drugs have new competitors.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

JANUARY 31, 2021

In addition to Metrion, these collaborations with Captor Therapeutics in targeted protein degradation and with PharmEnable to access proprietary artificial intelligence-enabled and medicinal chemistry technologies are a key factor to drive our future growth ambitions.”

Drugs 52

Drugs Protein In-Vitro Development 52

The Pharma Data

OCTOBER 28, 2020

An adverse effect on revenue has been observed in some of our therapeutic areas, such as Neuroscience, for reasons such as patients visiting their medical care providers less frequently for non-life-threatening and chronic diseases. Gastroenterology The Gastroenterology franchise with JPY 379.8 EU, and Japan. .

Sales 40

Sales Production Engineer Development 40

The Pharma Data

SEPTEMBER 15, 2020

Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3. The company announced the initiation of its Phase 1b clinical trial to evaluate the safety of a novel investigational therapeutic for COVID-19, PF-07304814. THERAPEUTIC AREAS OF FOCUS.

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

The Pharma Data

APRIL 27, 2021

vice president, global therapeutic area head, eye care, AbbVie. The proposed mechanism of action of AGN-190584 is through contraction of the iris sphincter muscle, constricting the pupil to enhance the depth of focus and improve near and intermediate visual acuity while maintaining some pupillary response to light. Robinson , M.D.,

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

The Pharma Data

JUNE 18, 2021

The depth of response achieved with this regimen is reflected in the 30-month progression-free survival (PFS) rate of ~95% across all treated patients, including the subset receiving placebo after the fixed-duration treatment. For more information about AbbVie, please visit us at www.abbvie.com.

Medicine 40

Medicine Production FDA Approval Trials 40